Loading market data...
markets

Novo Nordisk strikes second licensing deal since frosty capital-markets day

MarketWatchPaywall
Read Full Article at MarketWatch →
Share:PostShare
Ad Slot — In-Article (728x90)

Novo Nordisk said Tuesday the company struck its second licensing deal since it received a poor reception from investors after presenting its long-term strategy.

This is a summary. For the full story, read the original article at MarketWatch.

Original source: MarketWatch

Ad Slot — Below Article (300x250)